Moderate Wine Intake with Food May Help Decrease T2D Risk in Adults
Moderate consumption of alcohol with food was significantly associated with a 14% lower risk of type 2 diabetes in a preliminary analysis.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of March 7, 2022
Data from the CDC on boosters and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.
Obesity-related Comorbidities and Treatment: An Overview
An overview of common and uncommon obesity-related comorbidities and treatment strategies, here.
Routine Point-of-Care Screening for Afib in Primary Care May Be Most Useful in Oldest Adults
Routine point-of-care AF screening in primary care using a handheld ECG device proved feasible but increased diagnoses only in patients aged ≥85 years, in the VITAL-AF study.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of March 4, 2022
CDC: Uptake in Flu Vaccination is Down in Groups at High Risk for Complications
Drops in flu vaccine coverage this season have been recorded among young children and pregnant people and racial/ethnic gaps in uptake continue, says CDC.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of March 3, 2022
Tezepelumab Significantly Reduced Exacerbations in Patients with Severe Asthma, Respiratory Comorbidities
Tara Carr, MD, led a post hoc analysis of the NAVIGATOR phase 3 trial and presented data on tezepelumab efficacy in the vulnerable subgroup at the AAAAI 2022 meeting.
New CDC COVID-19 Community Level Metrics: Questions Patients May Have, Answers to Prep Clinicians
What questions might patients have about the CDC's new framework to measure COVID-19 community levels? Prep with our new slideshow.
Unmet Needs in US Migraine Headache Management: OVERCOME Study First Data
Findings on use of acute and preventive migraine therapy continue to reveal gaps with far more patients eligible than the proportions using either type.
Largest Genetic Study of Migraine to Date Identifies New Risk Factors
Researchers identified over 120 regions connected to risk of migraine, of which 86 were previously unknown.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of March 2, 2022
CDC: Americans Living in Low- or Medium-Risk Areas Can Leave Mask at Home
Approximately 70% of Americans live in areas deemed low or medium risk for severe COVID-19 and can go maskless, according to new formula used by CDC.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of March 1, 2022
CGM-measured Glucose Variability Associated with Diabetes Micro- and Macrovascular Complications
Glycemic variability and low time in range were associated with retinopathy, nephropathy, neuropathy, and CVD in a cohort of more than 20 000 persons, most with T2D.
Acute Migraine Treatment: A Guide to Medication Options
When choosing a migraine treatment for acute attack relief, the American Headache Society suggests following these steps.
Migraine Linked to Higher Risk of Pregnancy Complications in Preliminary Study
Researchers also found that women with migraine with aura had a higher risk of preeclampsia than those with migraine without aura.
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of February 28, 2022
Mepolizumab Clinically Effective Regardless of Type 2 Biomarker Status in Patients with Severe Asthma, Suggests Real-world Data
AAAAI 2022: Mepolizumab found effective in standard clinical care regardless of type 2 eosinophil biomarker status in patients with severe asthma.
Novel Agent for Severe Asthma Halves Exacerbation Rates Across Respiratory Comorbidities
Tezepelumab, a TSLP inhibitor, reduced asthma exacerbation rates in patients with severe uncontrolled disease across a range of respiratory comorbidities.
